Originally published by our sister publication Infectious Disease Special Edition
By Marie Rosenthal, MS
The CDC’s Advisory Committee on Immunization Practices (ACIP) recommended the use of meningococcal groups A, B, C, W and Y vaccine (MenABCWY; Penmenvy, GSK) as part of the adolescent meningococcal vaccination schedule to protect against disease-causing serogroups of Neisseria meningitidis (A, B, C, W and Y).
On Feb. 14, the FDA approved GSK’s MenABCWY vaccine, which combines the